Autoimmunity News

Wednesday, July 01, 2009 Masitinib Pilot Study Shows Promise in DMARD-resistant RA
The first drug to target mast cells in RA shows promising early results in an uncontrolled phase 2a trial...

Tuesday, June 23, 2009 MMF Effective, Safe for Proliferative as well as Membranous Lupus Nephritis
Mycophenolate mofetil (CellCept) may be as effective as, yet safer than, cyclophosphamide for the proliferative lupus glomerulonephritis...

Tuesday, May 26, 2009 Little Science Behind Most Alternative Raynaud’s Remedies
Many patients with Raynaud's phenomenon try alternatives to conventional care, but a new analysis finds little data to support use of most such approaches...

Thursday, May 14, 2009 FDA OKs UCB's Cimzia for Moderate to Severe RA
Cimzia^® (certolizumab pegol), the only pegylated anti-TNF, has been approved for use in the US...

Tuesday, April 28, 2009 RA Patients Could Be Hard Hit By Swine Flu
Rheumatologists must be vigilant in looking for signs and symptoms of the swine flu in their immunocompromised patients—including those on TNF-inhibitors...

Monday, April 27, 2009 Two Big Steps for Lupus Nephritis Research
Genes that encode CXCR4/CXCL12 and kallikrein help determine whether lupus patients will develop kidney damage...

Tuesday, April 21, 2009 Lupus Damage at 10 Years Predicts Mortality
More than half of all lupus patients accrue damage within 10 years of their diagnosis, and these patients are at greater risk for death as a result...

Thursday, April 09, 2009 Rituximab May Help Some Severe Lupus Nephritis Cases
Rituximab treatment that achieves early B-cell depletion in cases of severe lupus nephritis can induced complete or partial remission in 60% of patients...

Monday, April 06, 2009 Gene May Explain Women's Heightened Lupus Risk
A gene on the X chromosome may be linked to lupus, explaining why women are much more likely to develop the disease than men...

Thursday, March 26, 2009 Firefly Protein Lights Up Lupus Imaging
Bioluminescent imaging of NF-kB pinpoints inflamed sites long before symptoms appear in a mouse model of lupus and is likely to speed development of treatments for early disease...